Comparison of 12-Month Visual Outcomes and Patient-Reported Measures between the BVI Isopure Enhanced Monofocal IOL and the AcrySof IQ Monofocal IOL
Korean Journal of Ophthalmology · 16.11.2026
DOI: 10.3341/kjo.2026.0076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Korean Journal of Ophthalmology, online erschienen am 16.11.2026. Verfasst von Seul Gi Lim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Abstract (Originalsprache)
Purpose
To compare 12-month visual, refractive, and patient-reported outcomes between the BVI Isopure enhanced monofocal intraocular lens (IOL) and the AcrySof IQ monofocal IOL after cataract surgery.
Methods
This retrospective comparative study included 40 eyes implanted with either BVI Isopure or AcrySof IQ. Outcomes at 1 and 12 months included visual acuity, refractive outcomes, distance-corrected defocus curves, dysphotopsia, spectacle dependence, and patient satisfaction; contrast sensitivity was evaluated at 1 month only. Continuous eye-level outcomes were primarily analyzed using linear mixed-effects models accounting for inter-eye correlation, whereas defocus curves were presented descriptively and patient-reported outcomes were analyzed at the patient level.
Results
Sixteen BVI Isopure eyes and 24 AcrySof IQ eyes were analyzed. Defocus curves showed a numerical tendency toward better intermediate performance with BVI Isopure. BVI Isopure showed significantly lower patient-reported spectacle dependence for near, intermediate, and distance vision at 1 month and for near vision at 12 months, whereas AcrySof IQ showed significantly higher mesopic contrast sensitivity without glare at 6, 12, and 18 cycles/degree. No statistically significant between-group differences were observed in distance visual acuity or refractive predictability at either time point. Contrast sensitivity did not differ significantly under photopic without-glare or mesopic-with-glare conditions, and dysphotopsia scores and patient satisfaction did not differ significantly between groups.
Conclusions
BVI Isopure showed lower patient-reported spectacle dependence at selected distances and time points, whereas AcrySof IQ showed higher mesopic contrast sensitivity without glare at several spatial frequencies. Defocus curves also showed a numerical tendency toward better intermediate performance with BVI Isopure. These exploratory findings warrant confirmation in larger, adequately powered prospective studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. ldhlse@gmail.com.
Zitieren
APA
Lim, S. G., & Lim, D. H. (2026). Comparison of 12-Month Visual Outcomes and Patient-Reported Measures between the BVI Isopure Enhanced Monofocal IOL and the AcrySof IQ Monofocal IOL. Korean Journal of Ophthalmology. https://doi.org/10.3341/kjo.2026.0076
Vancouver
Lim SG, Lim DH. Comparison of 12-Month Visual Outcomes and Patient-Reported Measures between the BVI Isopure Enhanced Monofocal IOL and the AcrySof IQ Monofocal IOL. Korean Journal of Ophthalmology. 2026. doi:10.3341/kjo.2026.0076
BibTeX
@article{Lim2026,
author = {Lim, Seul Gi and Lim, Dong Hui},
title = {Comparison of 12-Month Visual Outcomes and Patient-Reported Measures between the BVI Isopure Enhanced Monofocal IOL and the AcrySof IQ Monofocal IOL},
journal = {Korean Journal of Ophthalmology},
year = {2026},
doi = {10.3341/kjo.2026.0076}
}
EUVIMED